Tech Mogul Bryan Johnson Embraces Magic Mushrooms in Quest for Longevity

Bryan Johnson, a multimillionaire tech mogul known for his unconventional anti-aging strategies, has added psilocybin mushrooms to his regimen in a bid to extend his lifespan. Johnson, who has made headlines for his extreme biohacking practices, is now experimenting with macrodosing magic mushrooms as part of his quest to defy death. This new venture is consistent with his belief that technology and unconventional methods can help humans achieve immortality

Johnson's journey into psychedelics is not new; he has previously experimented with substances such as LSD and ketamine. His latest endeavor involves taking nearly five grams of psilocybin mushrooms once a month over three months, a dose known as a 'heroic dose' for its intensity. This experiment is conducted under medical supervision, with Johnson meticulously monitoring a vast array of biomarkers to assess the impact on his longevity and overall health

The tech mogul's fascination with anti-aging and biohacking is well-documented. Johnson has previously engaged in controversial practices such as blood transfusions from his teenage son and consuming over 100 pills daily. He has also been the subject of a Netflix documentary, where he claims to have reversed his biological age by over five years. Despite skepticism from the medical community, Johnson remains steadfast in his belief that death is a choice rather than an inevitability

Johnson's public persona is closely tied to his business ventures, including his company Blueprint, which sells supplements purported to enhance health and longevity. His approach to life and death often raises eyebrows, with critics questioning whether his intense self-monitoring is a manifestation of a desire for control. Nonetheless, Johnson's experiments spark discussions about the potential of psychedelics in promoting mental and physical well-being

The use of psilocybin mushrooms is gaining attention in scientific circles for their potential therapeutic benefits, including improving mental health and enhancing neuroplasticity. Johnson's experiment, while unconventional, aligns with broader research exploring psychedelics' role in treating conditions like depression and anxiety. However, it is important to note that psilocybin is not approved by the FDA for longevity, and its effects remain under investigation

As Johnson continues his psychedelic journey, he shares his experiences on social media, describing profound changes in his mindset and emotional state. His recent tweets reflect a newfound appreciation for life and a sense of interconnectedness with the universe. While it remains to be seen whether mushrooms will indeed contribute to his goal of defying mortality, Johnson's experiment highlights the growing interest in psychedelics as a tool for personal growth and health optimization